A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukaemia (T-ALL) who have exhausted all standard treatment ...

Staying hopeful in challenging times. One Swanton graduate is doing just that as she searches for a bone marrow match that ...

Dr Oh added that about 80 per cent of such cases respond to conventional treatments such as chemotherapy and bone marrow ...

CINCINNATI (WKRC) - The Christ Hospital Health Network is offering a free online program this Breast Cancer Awareness Month to help women learn more about breast cancer prevention and treatment. The ...

Ricki Fairley is a Triple Negative Breast Cancer Survivor/Thriver and the CEO of TOUCH, The Black Breast Cancer Alliance. As an award-winning marketing ...

Research has shown that among patients with advanced non-small cell lung cancer, early palliative care delivered by video is ...

A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

BriaCell Therapeutics announced that its Bria-IMT cell therapy, plus an immune checkpoint inhibitor regimen, achieved ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today ...

Researchers at Medicine have uncovered a new mechanism that controls a special group of immune cells known as regulatory ...

In this webinar, Christoph Herbel will discuss multiplexed spatial analyses that identify ovarian tumor antigens and CAR T ...